Document_and_Entity_Informatio
Document and Entity Information | 6 Months Ended |
Jan. 31, 2015 | |
Entity Information | |
Entity Registrant Name | OIL DRI CORP OF AMERICA |
Entity Central Index Key | 74046 |
Current Fiscal Year End Date | -24 |
Entity Filer Category | Accelerated Filer |
Document Type | 10-Q |
Document Period End Date | 31-Jan-15 |
Document Fiscal Year Focus | 2015 |
Document Fiscal Period Focus | Q2 |
Amendment Flag | FALSE |
Common Stock | |
Entity Information | |
Entity Common Stock, Shares Outstanding | 5,016,942 |
Common Class B | |
Entity Information | |
Entity Common Stock, Shares Outstanding | 2,064,994 |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (USD $) | Jan. 31, 2015 | Jul. 31, 2014 |
In Thousands, unless otherwise specified | ||
Current Assets | ||
Cash and cash equivalents | $12,763 | $16,230 |
Restricted cash | 0 | 129 |
Short-term investments | 940 | 2,640 |
Accounts receivable, less allowance of $834 and $707 at January 31, 2015 and July 31, 2014, respectively | 32,255 | 30,997 |
Inventories | 23,661 | 24,483 |
Deferred income taxes | 1,570 | 1,570 |
Prepaid repairs expense | 3,618 | 3,722 |
Prepaid expenses and other assets | 2,221 | 3,745 |
Total Current Assets | 77,028 | 83,516 |
Property, Plant and Equipment | ||
Cost | 206,082 | 199,095 |
Less accumulated depreciation and amortization | -126,380 | -124,199 |
Total Property, Plant and Equipment, Net | 79,702 | 74,896 |
Other Assets | ||
Goodwill | 9,034 | 9,034 |
Trademarks and patents, net of accumulated amortization of $309 and $420 at January 31, 2015 and July 31, 2014, respectively | 751 | 660 |
Debt issuance costs, net of accumulated amortization of $407 and $522 at January 31, 2015 and July 31 2014, respectively | 194 | 243 |
Licensing agreements and non-compete agreements, net of accumulated amortization of $1,238 and $1,145 at January 31, 2015 and July 31, 2014, respectively | 62 | 155 |
Customer list, net of accumulated amortization of $1,428 and $764 at January 31, 2015 and July 31, 2014, respectively | 6,356 | 7,020 |
Deferred income taxes | 4,323 | 4,448 |
Other | 6,864 | 6,232 |
Total Other Assets | 27,584 | 27,792 |
Total Assets | 184,314 | 186,204 |
Current Liabilities | ||
Current maturities of notes payable | 3,483 | 3,500 |
Accounts payable | 6,191 | 7,352 |
Dividends payable | 1,313 | 1,311 |
Accrued expenses: | ||
Salaries, wages and commissions | 4,470 | 4,448 |
Trade promotions and advertising | 3,020 | 2,182 |
Freight | 2,750 | 2,504 |
Other | 6,493 | 8,203 |
Total Current Liabilities | 27,720 | 29,500 |
Noncurrent Liabilities | ||
Notes payable | 15,417 | 18,900 |
Deferred compensation | 9,624 | 9,267 |
Pension and postretirement benefits | 22,600 | 22,273 |
Other | 2,026 | 1,956 |
Total Noncurrent Liabilities | 49,667 | 52,396 |
Total Liabilities | 77,387 | 81,896 |
Stockholders’ Equity | ||
Additional paid-in capital | 33,467 | 33,130 |
Restricted unearned stock compensation | -1,829 | -2,225 |
Retained earnings | 138,330 | 136,039 |
Accumulated other comprehensive income: | ||
Unrealized gain on marketable securities | 0 | 114 |
Pension and postretirement benefits | -8,440 | -8,632 |
Cumulative translation adjustment | -182 | 255 |
Total accumulated other comprehensive loss | -8,622 | -8,263 |
Less Treasury Stock, at cost (2,917,151 Common and 324,741 Class B shares at January 31, 2015 and 2,915,651 Common and 324,741 Class B shares at July 31, 2014) | -55,451 | -55,404 |
Total Stockholders' Equity | 106,927 | 104,308 |
Total Liabilities & Stockholders’ Equity | 184,314 | 186,204 |
Common Stock | ||
Stockholders’ Equity | ||
Common Stock, par value $.10 per share | 793 | 792 |
Common Class B | ||
Stockholders’ Equity | ||
Common Stock, par value $.10 per share | $239 | $239 |
Condensed_Consolidated_Balance1
Condensed Consolidated Balance Sheet Parenthetical (USD $) | Jan. 31, 2015 | Jul. 31, 2014 |
In Thousands, except Share data, unless otherwise specified | ||
Current Assets | ||
Allowance for doubtful accounts | $834 | $707 |
Other Assets | ||
Accumulated amortization Trademarks and patents | 309 | 420 |
Accumulated amortization Debt issuance costs | 407 | 522 |
Accumulated amortization Licensing and non-compete agreements | 1,238 | 1,145 |
Accumulated amortization Customer lists | $1,428 | $764 |
Common Stock | ||
Stockholder's Equity | ||
Common stock, par value (in dollars per share) | $0.10 | $0.10 |
Common stock, shares issued | 7,934,093 | 7,917,393 |
Treasury stock, common shares | 2,917,151 | 2,915,651 |
Common Class B | ||
Stockholder's Equity | ||
Common stock, par value (in dollars per share) | $0.10 | $0.10 |
Common stock, shares issued | 2,389,735 | 2,394,735 |
Treasury stock, common shares | 324,741 | 324,741 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Income and Retained Earnings (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 |
Net Sales | $64,643 | $69,305 | $130,687 | $132,851 |
Cost of Sales | -49,410 | -52,412 | -101,685 | -99,458 |
Gross Profit | 15,233 | 16,893 | 29,002 | 33,393 |
Selling, General and Administrative Expenses | -10,952 | -11,159 | -21,561 | -23,317 |
Income from Operations | 4,281 | 5,734 | 7,441 | 10,076 |
Other Income (Expense) | ||||
Interest expense | -307 | -385 | -689 | -809 |
Interest income | 2 | 6 | 5 | 16 |
Other, net | -90 | 175 | -6 | 140 |
Total Other Income (Expense), Net | -395 | -204 | -690 | -653 |
Income Before Income Taxes | 3,886 | 5,530 | 6,751 | 9,423 |
Income taxes | -1,089 | -1,249 | -1,834 | -2,255 |
Net Income | 2,797 | 4,281 | 4,917 | 7,168 |
Retained Earnings | ||||
Balance at beginning of period | 136,039 | 132,750 | ||
Cash dividends declared and treasury stock issuances | -2,626 | -2,496 | ||
Balance at end of period | $138,330 | $137,422 | $138,330 | $137,422 |
Net Income Per Share | ||||
Diluted (in dollars per share) | $0.39 | $0.60 | $0.69 | $1.01 |
Average Shares Outstanding | ||||
Diluted (in shares) | 7,030 | 7,007 | 7,023 | 6,991 |
Common Stock | ||||
Net Income Per Share | ||||
Basic Common (in dollars per share) | $0.43 | $0.65 | $0.75 | $1.09 |
Average Shares Outstanding | ||||
Basic Common (in shares) | 4,953 | 4,979 | 4,951 | 4,967 |
Dividends Declared (in dollars per share) | $0.20 | $0.19 | $0.40 | $0.38 |
Common Class B | ||||
Net Income Per Share | ||||
Basic Common (in dollars per share) | $0.32 | $0.49 | $0.56 | $0.82 |
Average Shares Outstanding | ||||
Basic Common (in shares) | 2,022 | 2,005 | 2,016 | 1,999 |
Dividends Declared (in dollars per share) | $0.15 | $0.14 | $0.30 | $0.28 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Income (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 |
Net Income | $2,797 | $4,281 | $4,917 | $7,168 |
Other Comprehensive Loss: | ||||
Unrealized gain (loss) on marketable securities | 0 | 6 | -114 | -2 |
Pension and postretirement benefits (net of tax) | 93 | 56 | 192 | 113 |
Cumulative translation adjustment | -352 | -227 | -437 | -294 |
Other Comprehensive Loss | -259 | -165 | -359 | -183 |
Total Comprehensive Income | $2,538 | $4,116 | $4,558 | $6,985 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements of Cash Flows (USD $) | 6 Months Ended | |
In Thousands, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net Income | $4,917 | $7,168 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation and amortization | 5,936 | 4,860 |
Amortization of investment net discount | -1 | -2 |
Non-cash stock compensation expense | 656 | 560 |
Excess tax benefits for share-based payments | -16 | -21 |
Deferred income taxes | 166 | 79 |
Provision for bad debts and cash discounts | 173 | 45 |
Loss on the sale of fixed assets | 118 | 13 |
Gain on sale of marketable securities | -105 | 0 |
(Increase) Decrease in assets: | ||
Accounts receivable | -1,431 | -5,919 |
Inventories | 822 | -1,347 |
Prepaid expenses | 1,628 | -725 |
Other assets | -1,205 | -312 |
Increase (Decrease) in liabilities: | ||
Accounts payable | -1,232 | 381 |
Accrued expenses | -867 | -3,558 |
Deferred compensation | 357 | 407 |
Pension and postretirement benefits | 519 | 528 |
Other liabilities | 172 | 243 |
Total Adjustments | 5,690 | -4,768 |
Net Cash Provided by Operating Activities | 10,607 | 2,400 |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Capital expenditures | -9,920 | -6,782 |
Proceeds from sale of property, plant and equipment | 15 | 16 |
Acquisition of business | 0 | -12,505 |
Restricted cash | 129 | -500 |
Purchases of short-term investments | -700 | -7,991 |
Dispositions of short-term investments | 2,401 | 19,352 |
Proceeds from sale of marketable securities | 108 | 0 |
Net Cash Used in Investing Activities | -7,967 | -8,410 |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Principal payments on notes payable | -3,500 | -3,500 |
Dividends paid | -2,623 | -2,478 |
Purchase of treasury stock | 0 | -13 |
Proceeds from issuance of treasury stock | 0 | 39 |
Proceeds from issuance of common stock | 15 | 12 |
Excess tax benefits for share-based payments | 16 | 21 |
Net Cash Used in Financing Activities | -6,092 | -5,919 |
Effect of exchange rate changes on cash and cash equivalents | -15 | -24 |
Net Decrease in Cash and Cash Equivalents | -3,467 | -11,953 |
Cash and Cash Equivalents, Beginning of Period | 16,230 | 24,035 |
Cash and Cash Equivalents, End of Period | 12,763 | 12,082 |
Noncash transactions in Accounts payable | ||
Supplemental disclosure of non-cash investing activities: | ||
Capital expenditures incurred but not yet paid | 661 | 1,184 |
Noncash transactions in Accrued expenses | ||
Supplemental disclosure of non-cash investing activities: | ||
Capital expenditures incurred but not yet paid | $359 | $46 |
Basis_of_Statement_Presentatio
Basis of Statement Presentation | 6 Months Ended |
Jan. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Statement Presentation | BASIS OF STATEMENT PRESENTATION |
The accompanying unaudited condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements and the related notes are condensed and should be read in conjunction with the Consolidated Financial Statements and related notes for the year ended July 31, 2014 included in our Annual Report on Form 10-K filed with the SEC. | |
The unaudited condensed Consolidated Financial Statements include the accounts of Oil-Dri Corporation of America and its subsidiaries. All significant intercompany transactions are eliminated. Except as otherwise indicated herein or as the context otherwise requires, references to “Oil-Dri,” the “Company,” “we,” “us” or “our” refer to Oil-Dri Corporation of America and its subsidiaries. | |
The unaudited condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals, which are, in the opinion of management, necessary for a fair presentation of the statements contained herein. Operating results for the three and six months ended January 31, 2015 are not necessarily an indication of the results that may be expected for the fiscal year ending July 31, 2015. | |
The preparation of the unaudited condensed Consolidated Financial Statements in conformity with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Estimates and assumptions are revised periodically. Actual results could differ from these estimates. | |
We recognize revenue when risk of loss and title are transferred under the terms of our sales agreements with customers at a fixed and determinable price and collection of payment is probable. Trade promotion reserves are provided for sales incentives made directly to consumers, such as coupons, and sales incentives made to customers, such as slotting, discounts based on sales volume, cooperative marketing programs and other arrangements. Such trade promotion costs are netted against sales. Sales returns and allowances are not material. | |
Selling, general and administrative expenses include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all advertising and marketing-related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation and amortization related to assets outside the manufacturing and distribution process and all other non-manufacturing and non-distribution expenses. | |
We record an allowance for doubtful accounts based on our historical experience and a periodic review of our accounts receivable, including a review of the overall aging of accounts and analysis of specific customer accounts. A customer account is determined to be uncollectible when we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment. | |
We mine sorbent materials on property that we either own or lease as part of our overall operations. A significant part of our overall mining cost is incurred during the process of removing the overburden (non-usable material) from the mine site, thus exposing the sorbent material used in a majority of our production processes. These stripping costs are treated as a variable inventory production cost and are included in cost of sales in the period they are incurred. We defer and amortize the pre-production overburden removal costs associated with opening a new mine. | |
Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal fees, survey fees and real estate fees. The costs of obtaining mineral patents, including legal fees and drilling expenses, are also capitalized. Pre-production development costs on new mines and any prepaid royalties that may be offset against future royalties due upon extraction of the minerals are also capitalized. All exploration related costs are expensed as incurred. | |
We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, thereby minimizing the costs associated with the reclamation process. |
New_Accounting_Pronouncements
New Accounting Pronouncements | 6 Months Ended |
Jan. 31, 2015 | |
NEW ACCOUNTING PRONOUNCEMENTS [Abstract] | |
New Accounting Pronouncements | NEW ACCOUNTING PRONOUNCEMENTS |
Recently Adopted Accounting Standards | |
The tangible property regulations ("repair regulations") released by the Internal Revenue Service in September 2013 under Sections 162(a) and 263(a) of the Internal Revenue Code were effective for our tax year beginning August 1, 2014. The repair regulations provide guidance regarding the timing of deductions and the capitalization of amounts paid to acquire, produce or improve tangible property. We believe our accounting policies comply with the requirements of the repair regulations and there is no material impact | |
on our Consolidated Financial Statements. | |
Recently Issued Regulations | |
In May 2014, the FASB issued guidance under ASC 250, Revenue from Contract with Customers, which establishes a single comprehensive revenue recognition model for all contracts with customers and will supersede most existing revenue guidance. This guidance requires entities to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled to receive in exchange. Transition options include either a full or modified retrospective approach and early adoption is not permitted. This guidance will be effective at the beginning of our first quarter of fiscal 2017. We are currently evaluating the impact of the adoption of this requirement on our Consolidated Financial Statements. | |
In August 2014, the FASB issued guidance under ASC 205, Presentation of Financial Statements - Going Concern, which defines management's responsibility to evaluate whether there is substantial doubt about an organization's ability to continue as a going concern and to provide related footnote disclosures. This guidance will be effective for our fiscal year ended July 31, 2017. We are currently evaluating the impact of the adoption of this requirement on our Consolidated Financial Statements. |
Inventories
Inventories | 6 Months Ended | |||||||
Jan. 31, 2015 | ||||||||
Inventory Disclosure [Abstract] | ||||||||
Inventories | INVENTORIES | |||||||
The composition of inventories is as follows (in thousands): | ||||||||
January 31, | July 31, | |||||||
2015 | 2014 | |||||||
Finished goods | $ | 13,234 | $ | 14,326 | ||||
Packaging | 5,226 | 5,402 | ||||||
Other | 5,201 | 4,755 | ||||||
Total Inventories | $ | 23,661 | $ | 24,483 | ||||
Inventories are valued at the lower of cost (first-in, first-out) or market. Inventory costs include the cost of raw materials, packaging supplies, labor and other overhead costs. We perform a detailed review of our inventory items to determine if an obsolescence reserve adjustment is necessary. The review surveys all of our operating facilities and sales groups to ensure that both historical issues and new market trends are considered. The obsolescence reserve not only considers specific items, but also takes into consideration the overall value of the inventory as of the balance sheet date. The inventory obsolescence reserve values at January 31, 2015 and July 31, 2014 were $483,000 and $390,000, respectively. |
Fair_Value_Measurements
Fair Value Measurements | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||
Fair Value Measurements | FAIR VALUE MEASUREMENTS | |||||||||||||||
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized into categories based on the lowest level of input that is significant to the fair value measurement. The categories in the hierarchy are as follows: | ||||||||||||||||
Level 1: | Financial assets and liabilities whose values are based on quoted market prices in active markets for identical assets or liabilities. | |||||||||||||||
Level 2: | Financial assets and liabilities whose values are based on: | |||||||||||||||
1) Quoted prices for similar assets or liabilities in active markets. | ||||||||||||||||
2) Quoted prices for identical or similar assets or liabilities in markets that are not active. | ||||||||||||||||
3) Valuation models whose inputs are observable, directly or indirectly, for substantially the full term of the asset or liability. | ||||||||||||||||
Level 3: | Financial assets and liabilities whose values are based on valuation techniques that require inputs that are unobservable. These inputs may reflect estimates of the assumptions that market participants would use in valuing the financial assets and liabilities. | |||||||||||||||
The following table summarizes our financial assets and liabilities that were measured at fair value by level within the fair value hierarchy: | ||||||||||||||||
Fair Value at January 31, 2015 | Fair Value at July 31, 2014 | |||||||||||||||
(in thousands) | (in thousands) | |||||||||||||||
Total | Level 1 | Total | Level 1 | |||||||||||||
Assets | ||||||||||||||||
Cash equivalents | $ | 3,052 | $ | 3,052 | $ | 5,728 | $ | 5,728 | ||||||||
Marketable equity securities | — | — | 117 | 117 | ||||||||||||
Cash equivalents were classified as Level 1 of the fair value hierarchy because they were valued using quoted market prices in active markets. These cash instruments are primarily money market mutual funds and are included in cash and cash equivalents on the condensed Consolidated Balance Sheets. | ||||||||||||||||
Marketable equity securities were valued using quoted market prices in active markets and as such are classified as Level 1 in the fair value hierarchy. We owned stock in one publicly traded company at July 31, 2014, which was included in other assets on the condensed Consolidated Balance Sheets. We sold the stock of this company in the first quarter of fiscal 2015 after it was acquired by another company. | ||||||||||||||||
Short-term investments on the condensed Consolidated Balance Sheets included U.S. Treasury securities and certificates of deposit. We intend and have the ability to hold our short-term investments to maturity; therefore, these investments were reported at amortized cost on the condensed Consolidated Balance Sheets, which approximated fair value as of January 31, 2015 and July 31, 2014. These balances are excluded from the above table. | ||||||||||||||||
Accounts receivable and accounts payable balances on the condensed Consolidated Balance Sheets approximated their fair values at January 31, 2015 and July 31, 2014 due to the short maturity and nature of those balances; therefore, these balances are excluded from the above table. | ||||||||||||||||
Prepaid expenses and other assets on the condensed Consolidated Balance Sheets as of July 31, 2014 included a receivable of $255,000 related to our acquisition of certain assets of MFM Industries Inc. ("MFM") during fiscal 2014. This receivable is excluded from the above table. The receivable represented the estimated amount due to us upon the sale of the real property retained by MFM. We evaluated the value of this receivable during fiscal 2015 and reduced the balance to $114,500 as of the end of the first quarter of fiscal 2015. We received $116,000 in settlement upon sale of the land during the second quarter of fiscal 2015, thereby eliminating the receivable balance as of January 31, 2015. | ||||||||||||||||
Notes payable on the condensed Consolidated Balance Sheets are carried at the face amount of future maturities and are excluded from the above table. The estimated fair value of notes payable, including current maturities, was $20,039,000 and $23,940,000 as of January 31, 2015 and July 31, 2014, respectively. Our debt does not trade on a daily basis in an active market, therefore the fair value estimate is based on market observable borrowing rates currently available for debt with similar terms and average maturities and is classified as Level 2. | ||||||||||||||||
We apply fair value techniques on at least an annual basis associated with: (1) valuing potential impairment loss related to goodwill, trademarks and other indefinite-lived intangible assets and (2) valuing potential impairment loss related to long-lived assets. See Note 5 for further information about goodwill and other intangible assets. |
Goodwill_and_Other_Intangibles
Goodwill and Other Intangibles (Notes) | 6 Months Ended | |||
Jan. 31, 2015 | ||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Goodwill and Other Intangible Assets | GOODWILL AND OTHER INTANGIBLE ASSETS | |||
Intangible amortization expense was $400,000 and $337,000 in the second quarter of fiscal 2015 and 2014, respectively. Intangible amortization expense was $820,000 and $425,000 for the first six months of fiscal 2015 and 2014, respectively. Estimated intangible amortization for the remainder of fiscal 2015 is $788,000. Estimated intangible amortization for the next five fiscal years is as follows (in thousands): | ||||
2016 | $ | 1,416 | ||
2017 | $ | 1,188 | ||
2018 | $ | 979 | ||
2019 | $ | 792 | ||
2020 | $ | 621 | ||
We have one acquired trademark recorded at $376,000 that was determined to have an indefinite life and is not amortized. | ||||
Our annual goodwill impairment analysis was performed in the first quarter of fiscal 2015 and did not indicate any impairment. |
Pension_and_Other_Postretireme
Pension and Other Postretirement Benefits | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] | ||||||||||||||||
Pension and Other Postretirement Benefits Disclosure | PENSION AND OTHER POSTRETIREMENT BENEFITS | |||||||||||||||
The components of net periodic pension and postretirement health benefit costs were as follows: | ||||||||||||||||
Pension Benefits | ||||||||||||||||
(in thousands) | ||||||||||||||||
For the Three Months Ended January 31, | For the Six Months Ended January 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Service cost | $ | 371 | $ | 361 | $ | 803 | $ | 721 | ||||||||
Interest cost | 457 | 435 | 925 | 871 | ||||||||||||
Expected return on plan assets | (469 | ) | (429 | ) | (939 | ) | (858 | ) | ||||||||
Amortization of: | ||||||||||||||||
Prior service costs | 3 | 4 | 5 | 7 | ||||||||||||
Other actuarial loss | 139 | 78 | 289 | 156 | ||||||||||||
Net periodic benefit cost | $ | 501 | $ | 449 | $ | 1,083 | $ | 897 | ||||||||
Postretirement Health Benefits | ||||||||||||||||
(in thousands) | ||||||||||||||||
For the Three Months Ended January 31, | For the Six Months Ended January 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Service cost | $ | 34 | $ | 30 | $ | 67 | $ | 60 | ||||||||
Interest cost | 26 | 29 | 53 | 58 | ||||||||||||
Amortization of: | ||||||||||||||||
Net transition obligation | — | 4 | — | 8 | ||||||||||||
Prior service costs | (1 | ) | (2 | ) | (3 | ) | (3 | ) | ||||||||
Other actuarial loss | 9 | 8 | 18 | 15 | ||||||||||||
Net periodic benefit cost | $ | 68 | $ | 69 | $ | 135 | $ | 138 | ||||||||
The postretirement health plan is an unfunded plan. We pay insurance premiums and claims from our assets. | ||||||||||||||||
The pension plan is funded based upon actuarially determined contributions that take into account the amount deductible for income tax purposes, the normal cost and the minimum contribution required and the maximum contribution allowed under applicable regulations. We contributed $350,000 and $581,000 to our pension plan during the second quarter and first six months of fiscal 2015, respectively. We estimate contributions will be $1,276,000 for the remainder of fiscal 2015. See Item 3. "Quantitative and Qualitative Disclosures About Market Risk" for a discussion of the potential impact of financial market fluctuations on pension plan assets and future funding contributions. | ||||||||||||||||
Assumptions used in the previous calculations were as follows: | ||||||||||||||||
Pension Benefits | Postretirement Health Benefits | |||||||||||||||
For the Three and Six Months Ended January 31, | ||||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Discount rate for net periodic benefit cost | 4.28 | % | 4.8 | % | 3.87 | % | 4.8 | % | ||||||||
Rate of increase in compensation levels | 3.5 | % | 3.5 | % | — | — | ||||||||||
Long-term expected rate of return on assets | 7.5 | % | 7.5 | % | — | — | ||||||||||
The medical cost trend assumption for postretirement health benefits was 7.5%. The graded trend rate is expected to decrease to an ultimate rate of 5.0% in fiscal 2024. |
Operating_Segment
Operating Segment | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||
Operating Segment Disclosure | OPERATING SEGMENTS | |||||||||||||||
We have two operating segments: (1) Retail and Wholesale Products Group and (2) Business to Business Products Group. These operating segments are managed separately and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include: mass merchandisers; wholesale clubs; drugstore chains; pet specialty retail outlets; dollar stores; retail grocery stores; distributors of industrial cleanup and automotive products; environmental service companies; and sports field product users. The Business to Business Products Group customers include: processors and refiners of edible oils, petroleum-based oils and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; distributors of animal health and nutrition products; and marketers of consumer products. | ||||||||||||||||
Our operating segments are also our reportable segments. Net sales and operating income for each segment are provided below. Revenues by product line are not provided because it would be impracticable to do so. The accounting policies of the segments are the same as those described in Note 1 of the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2014. | ||||||||||||||||
We do not rely on any segment asset allocations and we do not consider them meaningful because of the shared nature of our production facilities; however, we have estimated the segment asset allocations below for those assets for which we can reasonably determine. The unallocated asset category is the remainder of our total assets. The asset allocation is estimated and is not a measure used by our chief operating decision maker about allocating resources to the operating segments or in assessing their performance. The corporate expenses line includes certain unallocated expenses, including primarily salaries, wages and benefits, purchased services, rent, utilities and depreciation and amortization associated with corporate functions such as research and development, information systems, finance, legal, human resources and customer service. Corporate expenses also include the estimated annual incentive plan bonus accrual. | ||||||||||||||||
Assets | ||||||||||||||||
January 31, 2015 | July 31, 2014 | |||||||||||||||
(in thousands) | ||||||||||||||||
Business to Business Products | $ | 55,716 | $ | 53,823 | ||||||||||||
Retail and Wholesale Products | 95,768 | 95,712 | ||||||||||||||
Unallocated Assets | 32,830 | 36,669 | ||||||||||||||
Total Assets | $ | 184,314 | $ | 186,204 | ||||||||||||
For the Six Months Ended January 31, | ||||||||||||||||
Net Sales | Income | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
(in thousands) | ||||||||||||||||
Business to Business Products | $ | 46,695 | $ | 49,179 | $ | 14,314 | $ | 15,644 | ||||||||
Retail and Wholesale Products | 83,992 | 83,672 | 2,148 | 4,257 | ||||||||||||
Total Sales | $ | 130,687 | $ | 132,851 | ||||||||||||
Corporate Expenses | (9,021 | ) | (9,825 | ) | ||||||||||||
Income from Operations | 7,441 | 10,076 | ||||||||||||||
Total Other Expense, Net | (690 | ) | (653 | ) | ||||||||||||
Income before Income Taxes | 6,751 | 9,423 | ||||||||||||||
Income Taxes | (1,834 | ) | (2,255 | ) | ||||||||||||
Net Income | $ | 4,917 | $ | 7,168 | ||||||||||||
For the Three Months Ended January 31, | ||||||||||||||||
Net Sales | Income | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
(in thousands) | ||||||||||||||||
Business to Business Products | $ | 23,047 | $ | 25,264 | $ | 7,443 | $ | 7,993 | ||||||||
Retail and Wholesale Products | 41,596 | 44,041 | 1,262 | 2,982 | ||||||||||||
Total Sales | $ | 64,643 | $ | 69,305 | ||||||||||||
Corporate Expenses | (4,424 | ) | (5,241 | ) | ||||||||||||
Income from Operations | 4,281 | 5,734 | ||||||||||||||
Total Other Expense, Net | (395 | ) | (204 | ) | ||||||||||||
Income before Income Taxes | 3,886 | 5,530 | ||||||||||||||
Income Taxes | (1,089 | ) | (1,249 | ) | ||||||||||||
Net Income | $ | 2,797 | $ | 4,281 | ||||||||||||
StockBased_Compensation
Stock-Based Compensation | 6 Months Ended | ||||||||||||
Jan. 31, 2015 | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments | STOCK-BASED COMPENSATION | ||||||||||||
We determine the fair value of stock options and restricted stock issued under our long term incentive plans as of the grant date. We recognize the related compensation expense over the period from the date of grant to the date when the award is no longer contingent on the employee providing additional service to the Company. | |||||||||||||
The Oil-Dri Corporation of America 2006 Long Term Incentive Plan (the “2006 Plan”) permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 937,500. Stock options have been granted to our outside directors with a vesting period of one year and stock options granted to employees generally vest 25% two years after the grant date and in each of the three following anniversaries of the grant date. In addition, restricted shares have been issued under the 2006 Plan as described in the restricted stock section below. | |||||||||||||
Stock Options | |||||||||||||
A summary of stock option transactions is shown below: | |||||||||||||
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | ||||||||||
(in thousands) | (Years) | (in thousands) | |||||||||||
Options outstanding and exercisable, July 31, 2014 | 44 | $ | 15.43 | 1.9 | $ | 611 | |||||||
Exercised | (1 | ) | $ | 15.37 | $ | 13 | |||||||
Options outstanding and exercisable, January 31, 2015 | 43 | $ | 15.43 | 1.4 | $ | 661 | |||||||
There were no stock options exercised in the second quarter of either fiscal 2015 or 2014. The amount of cash received from the exercise of stock options during the first three months of fiscal 2015 was $15,000 and the related tax benefit was $3,000. The amount of cash received from the exercise of stock options during the first three months of fiscal 2014 was $51,000 and the related tax benefit was $24,000. | |||||||||||||
No stock options were granted in the first six months of either fiscal 2015 or 2014. | |||||||||||||
Restricted Stock | |||||||||||||
All of our non-vested restricted stock as of January 31, 2015 was issued under the 2006 Plan with vesting periods between two years and five years. | |||||||||||||
Under the 2006 Plan, 2,000 restricted shares of Common Stock were granted in the second quarter of fiscal year 2015. No restricted shares were granted in the second quarter of fiscal 2014. | |||||||||||||
Stock-based compensation expense related to non-vested restricted stock in the second quarter of fiscal years 2015 and 2014 was $348,000 and $319,000, respectively. In the first six months of fiscal years 2015 and 2014, the stock-based compensation expense related to non-vested restricted stock was $656,000 and $560,000, respectively. | |||||||||||||
A summary of restricted stock transactions is shown below: | |||||||||||||
Restricted Shares | Weighted Average Grant Date Fair Value | ||||||||||||
(in thousands) | |||||||||||||
Non-vested restricted stock outstanding at July 31, 2014 | 122 | $ | 27.31 | ||||||||||
Granted | 11 | $ | 28.68 | ||||||||||
Vested | (25 | ) | $ | 21.82 | |||||||||
Forfeitures | (2 | ) | $ | 31.15 | |||||||||
Non-vested restricted stock outstanding at January 31, 2015 | 106 | $ | 28.69 | ||||||||||
Accumulated_Other_Comprehensiv
Accumulated Other Comprehensive Income (Notes) | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Accumulated Other Comprehensive Income [Abstract] | ||||||||||||||||
Accumulated Other Comprehensive Income | ACCUMULATED OTHER COMPREHENSIVE INCOME | |||||||||||||||
The following table summarizes the changes in accumulated other comprehensive income by component as of January 31, 2015 (in thousands): | ||||||||||||||||
Unrealized Gain (Loss) on Marketable Securities | Pension and Postretirement Health Benefits | Cumulative Translation Adjustment | Total Accumulated Other Comprehensive Income | |||||||||||||
Balance as of July 31, 2014 | $ | 114 | $ | (8,632 | ) | $ | 255 | $ | (8,263 | ) | ||||||
Other comprehensive loss before reclassifications, net of tax | (9 | ) | — | (437 | ) | (446 | ) | |||||||||
Amounts reclassified from accumulated other comprehensive income (loss), net of tax | (105 | ) | a) | 192 | b) | — | 87 | |||||||||
Net current-period other comprehensive income (loss), net of tax | (114 | ) | 192 | (437 | ) | (359 | ) | |||||||||
Balance as of January 31, 2015 | $ | — | $ | (8,440 | ) | $ | (182 | ) | $ | (8,622 | ) | |||||
a) Amount is included in the condensed Consolidated Statements of Income on the Other, net line item. | ||||||||||||||||
b) Amount is net of tax expense of $117,000. Amount is included in the components of net periodic benefit cost for the pension and postretirement health plans. See Note 6 for further information. |
Basis_of_Statement_Presentatio1
Basis of Statement Presentation Level 2 (Policies) | 6 Months Ended |
Jan. 31, 2015 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Revenue Recognition | We recognize revenue when risk of loss and title are transferred under the terms of our sales agreements with customers at a fixed and determinable price and collection of payment is probable. Trade promotion reserves are provided for sales incentives made directly to consumers, such as coupons, and sales incentives made to customers, such as slotting, discounts based on sales volume, cooperative marketing programs and other arrangements. Such trade promotion costs are netted against sales. Sales returns and allowances are not material. |
Selling, General and Administrative Expenses | Selling, general and administrative expenses include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all advertising and marketing-related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation and amortization related to assets outside the manufacturing and distribution process and all other non-manufacturing and non-distribution expenses. |
Trade Receivable | We record an allowance for doubtful accounts based on our historical experience and a periodic review of our accounts receivable, including a review of the overall aging of accounts and analysis of specific customer accounts. A customer account is determined to be uncollectible when we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment. |
Overburden Removal and Mining Costs | We mine sorbent materials on property that we either own or lease as part of our overall operations. A significant part of our overall mining cost is incurred during the process of removing the overburden (non-usable material) from the mine site, thus exposing the sorbent material used in a majority of our production processes. These stripping costs are treated as a variable inventory production cost and are included in cost of sales in the period they are incurred. We defer and amortize the pre-production overburden removal costs associated with opening a new mine. |
Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal fees, survey fees and real estate fees. The costs of obtaining mineral patents, including legal fees and drilling expenses, are also capitalized. Pre-production development costs on new mines and any prepaid royalties that may be offset against future royalties due upon extraction of the minerals are also capitalized. All exploration related costs are expensed as incurred. | |
Reclamation | We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, thereby minimizing the costs associated with the reclamation process. |
Inventories_Level_2_Policies
Inventories Level 2 (Policies) | 6 Months Ended |
Jan. 31, 2015 | |
Inventory Disclosure [Abstract] | |
Inventories | Inventories are valued at the lower of cost (first-in, first-out) or market. Inventory costs include the cost of raw materials, packaging supplies, labor and other overhead costs. We perform a detailed review of our inventory items to determine if an obsolescence reserve adjustment is necessary. The review surveys all of our operating facilities and sales groups to ensure that both historical issues and new market trends are considered. The obsolescence reserve not only considers specific items, but also takes into consideration the overall value of the inventory as of the balance sheet date. |
Operating_Segment_Level_2_Poli
Operating Segment Level 2 (Policies) | 6 Months Ended |
Jan. 31, 2015 | |
Segment Reporting [Abstract] | |
Operating Segments | We have two operating segments: (1) Retail and Wholesale Products Group and (2) Business to Business Products Group. These operating segments are managed separately and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include: mass merchandisers; wholesale clubs; drugstore chains; pet specialty retail outlets; dollar stores; retail grocery stores; distributors of industrial cleanup and automotive products; environmental service companies; and sports field product users. The Business to Business Products Group customers include: processors and refiners of edible oils, petroleum-based oils and biodiesel fuel; manufacturers of animal feed and agricultural chemicals; distributors of animal health and nutrition products; and marketers of consumer products. |
Our operating segments are also our reportable segments. Net sales and operating income for each segment are provided below. Revenues by product line are not provided because it would be impracticable to do so. The accounting policies of the segments are the same as those described in Note 1 of the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2014. |
StockBased_Compensation_Level_
Stock-Based Compensation Level 2 (Policies) | 6 Months Ended |
Jan. 31, 2015 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Stock-based Compensation Policy | We determine the fair value of stock options and restricted stock issued under our long term incentive plans as of the grant date. We recognize the related compensation expense over the period from the date of grant to the date when the award is no longer contingent on the employee providing additional service to the Company. |
Inventories_Level_3_Tables
Inventories Level 3 (Tables) | 6 Months Ended | |||||||
Jan. 31, 2015 | ||||||||
Inventory Disclosure [Abstract] | ||||||||
Inventories | The composition of inventories is as follows (in thousands): | |||||||
January 31, | July 31, | |||||||
2015 | 2014 | |||||||
Finished goods | $ | 13,234 | $ | 14,326 | ||||
Packaging | 5,226 | 5,402 | ||||||
Other | 5,201 | 4,755 | ||||||
Total Inventories | $ | 23,661 | $ | 24,483 | ||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Fair Value Disclosures [Abstract] | ||||||||||||||||
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table summarizes our financial assets and liabilities that were measured at fair value by level within the fair value hierarchy: | |||||||||||||||
Fair Value at January 31, 2015 | Fair Value at July 31, 2014 | |||||||||||||||
(in thousands) | (in thousands) | |||||||||||||||
Total | Level 1 | Total | Level 1 | |||||||||||||
Assets | ||||||||||||||||
Cash equivalents | $ | 3,052 | $ | 3,052 | $ | 5,728 | $ | 5,728 | ||||||||
Marketable equity securities | — | — | 117 | 117 | ||||||||||||
Goodwill_and_Other_Intangibles1
Goodwill and Other Intangibles (Tables) | 6 Months Ended | |||
Jan. 31, 2015 | ||||
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense | Estimated intangible amortization for the next five fiscal years is as follows (in thousands): | |||
2016 | $ | 1,416 | ||
2017 | $ | 1,188 | ||
2018 | $ | 979 | ||
2019 | $ | 792 | ||
2020 | $ | 621 | ||
Pension_and_Other_Postretireme1
Pension and Other Postretirement Benefits (Tables) | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Defined Benefit Pension Plans and Defined Benefit Postretirement Plans Disclosure [Abstract] | ||||||||||||||||
Schedule of Net Benefit Costs | The components of net periodic pension and postretirement health benefit costs were as follows: | |||||||||||||||
Pension Benefits | ||||||||||||||||
(in thousands) | ||||||||||||||||
For the Three Months Ended January 31, | For the Six Months Ended January 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Service cost | $ | 371 | $ | 361 | $ | 803 | $ | 721 | ||||||||
Interest cost | 457 | 435 | 925 | 871 | ||||||||||||
Expected return on plan assets | (469 | ) | (429 | ) | (939 | ) | (858 | ) | ||||||||
Amortization of: | ||||||||||||||||
Prior service costs | 3 | 4 | 5 | 7 | ||||||||||||
Other actuarial loss | 139 | 78 | 289 | 156 | ||||||||||||
Net periodic benefit cost | $ | 501 | $ | 449 | $ | 1,083 | $ | 897 | ||||||||
Postretirement Health Benefits | ||||||||||||||||
(in thousands) | ||||||||||||||||
For the Three Months Ended January 31, | For the Six Months Ended January 31, | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Service cost | $ | 34 | $ | 30 | $ | 67 | $ | 60 | ||||||||
Interest cost | 26 | 29 | 53 | 58 | ||||||||||||
Amortization of: | ||||||||||||||||
Net transition obligation | — | 4 | — | 8 | ||||||||||||
Prior service costs | (1 | ) | (2 | ) | (3 | ) | (3 | ) | ||||||||
Other actuarial loss | 9 | 8 | 18 | 15 | ||||||||||||
Net periodic benefit cost | $ | 68 | $ | 69 | $ | 135 | $ | 138 | ||||||||
Schedule of Assumptions Used | Assumptions used in the previous calculations were as follows: | |||||||||||||||
Pension Benefits | Postretirement Health Benefits | |||||||||||||||
For the Three and Six Months Ended January 31, | ||||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
Discount rate for net periodic benefit cost | 4.28 | % | 4.8 | % | 3.87 | % | 4.8 | % | ||||||||
Rate of increase in compensation levels | 3.5 | % | 3.5 | % | — | — | ||||||||||
Long-term expected rate of return on assets | 7.5 | % | 7.5 | % | — | — | ||||||||||
The medical cost trend assumption for postretirement health benefits was 7.5%. The graded trend rate is expected to decrease to an ultimate rate of 5.0% in fiscal 2024. |
Operating_Segment_Tables
Operating Segment (Tables) | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Segment Reporting [Abstract] | ||||||||||||||||
Operating Segments Information | ||||||||||||||||
Assets | ||||||||||||||||
January 31, 2015 | July 31, 2014 | |||||||||||||||
(in thousands) | ||||||||||||||||
Business to Business Products | $ | 55,716 | $ | 53,823 | ||||||||||||
Retail and Wholesale Products | 95,768 | 95,712 | ||||||||||||||
Unallocated Assets | 32,830 | 36,669 | ||||||||||||||
Total Assets | $ | 184,314 | $ | 186,204 | ||||||||||||
For the Six Months Ended January 31, | ||||||||||||||||
Net Sales | Income | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
(in thousands) | ||||||||||||||||
Business to Business Products | $ | 46,695 | $ | 49,179 | $ | 14,314 | $ | 15,644 | ||||||||
Retail and Wholesale Products | 83,992 | 83,672 | 2,148 | 4,257 | ||||||||||||
Total Sales | $ | 130,687 | $ | 132,851 | ||||||||||||
Corporate Expenses | (9,021 | ) | (9,825 | ) | ||||||||||||
Income from Operations | 7,441 | 10,076 | ||||||||||||||
Total Other Expense, Net | (690 | ) | (653 | ) | ||||||||||||
Income before Income Taxes | 6,751 | 9,423 | ||||||||||||||
Income Taxes | (1,834 | ) | (2,255 | ) | ||||||||||||
Net Income | $ | 4,917 | $ | 7,168 | ||||||||||||
For the Three Months Ended January 31, | ||||||||||||||||
Net Sales | Income | |||||||||||||||
2015 | 2014 | 2015 | 2014 | |||||||||||||
(in thousands) | ||||||||||||||||
Business to Business Products | $ | 23,047 | $ | 25,264 | $ | 7,443 | $ | 7,993 | ||||||||
Retail and Wholesale Products | 41,596 | 44,041 | 1,262 | 2,982 | ||||||||||||
Total Sales | $ | 64,643 | $ | 69,305 | ||||||||||||
Corporate Expenses | (4,424 | ) | (5,241 | ) | ||||||||||||
Income from Operations | 4,281 | 5,734 | ||||||||||||||
Total Other Expense, Net | (395 | ) | (204 | ) | ||||||||||||
Income before Income Taxes | 3,886 | 5,530 | ||||||||||||||
Income Taxes | (1,089 | ) | (1,249 | ) | ||||||||||||
Net Income | $ | 2,797 | $ | 4,281 | ||||||||||||
StockBased_Compensation_Tables
Stock-Based Compensation (Tables) | 6 Months Ended | ||||||||||||
Jan. 31, 2015 | |||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||
Schedule of Stock Options Activity | A summary of stock option transactions is shown below: | ||||||||||||
Number of Shares | Weighted Average Exercise Price | Weighted Average Remaining Contractual Term | Aggregate Intrinsic Value | ||||||||||
(in thousands) | (Years) | (in thousands) | |||||||||||
Options outstanding and exercisable, July 31, 2014 | 44 | $ | 15.43 | 1.9 | $ | 611 | |||||||
Exercised | (1 | ) | $ | 15.37 | $ | 13 | |||||||
Options outstanding and exercisable, January 31, 2015 | 43 | $ | 15.43 | 1.4 | $ | 661 | |||||||
Schedule of Restricted Stock Transactions | A summary of restricted stock transactions is shown below: | ||||||||||||
Restricted Shares | Weighted Average Grant Date Fair Value | ||||||||||||
(in thousands) | |||||||||||||
Non-vested restricted stock outstanding at July 31, 2014 | 122 | $ | 27.31 | ||||||||||
Granted | 11 | $ | 28.68 | ||||||||||
Vested | (25 | ) | $ | 21.82 | |||||||||
Forfeitures | (2 | ) | $ | 31.15 | |||||||||
Non-vested restricted stock outstanding at January 31, 2015 | 106 | $ | 28.69 | ||||||||||
Accumulated_Other_Comprehensiv1
Accumulated Other Comprehensive Income (Tables) | 6 Months Ended | |||||||||||||||
Jan. 31, 2015 | ||||||||||||||||
Accumulated Other Comprehensive Income [Abstract] | ||||||||||||||||
Accumulated Other Comprehensive Income by Component | The following table summarizes the changes in accumulated other comprehensive income by component as of January 31, 2015 (in thousands): | |||||||||||||||
Unrealized Gain (Loss) on Marketable Securities | Pension and Postretirement Health Benefits | Cumulative Translation Adjustment | Total Accumulated Other Comprehensive Income | |||||||||||||
Balance as of July 31, 2014 | $ | 114 | $ | (8,632 | ) | $ | 255 | $ | (8,263 | ) | ||||||
Other comprehensive loss before reclassifications, net of tax | (9 | ) | — | (437 | ) | (446 | ) | |||||||||
Amounts reclassified from accumulated other comprehensive income (loss), net of tax | (105 | ) | a) | 192 | b) | — | 87 | |||||||||
Net current-period other comprehensive income (loss), net of tax | (114 | ) | 192 | (437 | ) | (359 | ) | |||||||||
Balance as of January 31, 2015 | $ | — | $ | (8,440 | ) | $ | (182 | ) | $ | (8,622 | ) | |||||
a) Amount is included in the condensed Consolidated Statements of Income on the Other, net line item. | ||||||||||||||||
b) Amount is net of tax expense of $117,000. Amount is included in the components of net periodic benefit cost for the pension and postretirement health plans. See Note 6 for further information. | ||||||||||||||||
Inventories_Details
Inventories (Details) (USD $) | Jan. 31, 2015 | Jul. 31, 2014 |
In Thousands, unless otherwise specified | ||
Inventory | ||
Finished goods | $13,234 | $14,326 |
Packaging | 5,226 | 5,402 |
Other | 5,201 | 4,755 |
Total Inventories | $23,661 | $24,483 |
Inventories_Narrative_Details
Inventories Narrative (Details) (USD $) | Jan. 31, 2015 | Jul. 31, 2014 |
Inventory | ||
Inventory obsolescence reserve | $483,000 | $390,000 |
Fair_Value_Measurements_Detail
Fair Value Measurements (Details) (USD $) | Jan. 31, 2015 | Jul. 31, 2014 |
In Thousands, unless otherwise specified | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Cash equivalents | $3,052 | $5,728 |
Marketable equity securities | 0 | 117 |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | ||
Cash equivalents | 3,052 | 5,728 |
Marketable equity securities | $0 | $117 |
Fair_Value_Measurements_Narrat
Fair Value Measurements Narrative (Details) (USD $) | Jan. 31, 2015 | Oct. 31, 2014 | Jul. 31, 2014 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis | |||
Business Acquisition, Contingent receivable for proceeds of land sale | $0 | $114,500 | $255,000 |
Business Acquisition, Amount of contingency settlement | 116,000 | ||
Notes Payable, Fair Value | $20,039,000 | $23,940,000 |
Goodwill_and_Other_Intangibles2
Goodwill and Other Intangibles (Details) (USD $) | Jan. 31, 2015 |
In Thousands, unless otherwise specified | |
Finite-Lived Intangible Assets, Future Amortization Expense | |
2016 | $1,416 |
2017 | 1,188 |
2018 | 979 |
2019 | 792 |
2020 | $621 |
Goodwill_and_Other_Intangibles3
Goodwill and Other Intangibles Narrative (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 | |
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of intangible assets | $400,000 | $337,000 | $820,000 | $425,000 |
Finite-lived intangible assets, amortization expense for remainder of current fiscal year | 788,000 | 788,000 | ||
Indefinite-lived trademarks | 376,000 | 376,000 | ||
Goodwill impairment loss | $0 |
Pension_and_Other_Postretireme2
Pension and Other Postretirement Benefits (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 |
Pension Plan | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | $371 | $361 | $803 | $721 |
Interest cost | 457 | 435 | 925 | 871 |
Expected return on plan assets | -469 | -429 | -939 | -858 |
Amortization of Prior service costs | 3 | 4 | 5 | 7 |
Amortization of Other actuarial loss | 139 | 78 | 289 | 156 |
Net periodic benefit cost | 501 | 449 | 1,083 | 897 |
Postretirement Health Plan | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||||
Service cost | 34 | 30 | 67 | 60 |
Interest cost | 26 | 29 | 53 | 58 |
Amortization of Net transition obligation | 0 | 4 | 0 | 8 |
Amortization of Prior service costs | -1 | -2 | -3 | -3 |
Amortization of Other actuarial loss | 9 | 8 | 18 | 15 |
Net periodic benefit cost | $68 | $69 | $135 | $138 |
Pension_and_Other_Postretireme3
Pension and Other Postretirement Benefits Assumptions (Details) | 6 Months Ended | |
Jan. 31, 2015 | Jan. 31, 2014 | |
Pension Plan | ||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||
Discount rate for net periodic benefit cost | 4.28% | 4.80% |
Rate of increase in compensation levels | 3.50% | 3.50% |
Long-term expected rate of return on assets | 7.50% | 7.50% |
Postretirement Health Plan | ||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||
Discount rate for net periodic benefit cost | 3.87% | 4.80% |
Rate of increase in compensation levels | 0.00% | 0.00% |
Long-term expected rate of return on assets | 0.00% | 0.00% |
Pension_and_Other_Postretireme4
Pension and Other Postretirement Benefits Narrative (Details) (USD $) | 3 Months Ended | 6 Months Ended |
Jan. 31, 2015 | Jan. 31, 2015 | |
Pension Plan | ||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||
Employer contributions | $350,000 | $581,000 |
Estimated contributions in remainder of current fiscal year | $1,276,000 | |
Postretirement Health Plan | ||
Defined Benefit Plans and Other Postretirement Benefit Plans | ||
Medical Cost Trend Assumption | 7.50% | |
Ultimate Health Care Cost Trend Rate | 5.00% | |
Year that Rate Reaches Ultimate Trend Rate | 2024 | 2024 |
Operating_Segment_Details
Operating Segment (Details) (USD $) | 3 Months Ended | 6 Months Ended | |||
In Thousands, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 | Jul. 31, 2014 |
Segment Reporting Information | |||||
Assets | $184,314 | $184,314 | $186,204 | ||
Total Sales | 64,643 | 69,305 | 130,687 | 132,851 | |
Corporate Expenses | -4,424 | -5,241 | -9,021 | -9,825 | |
Income from Operations | 4,281 | 5,734 | 7,441 | 10,076 | |
Total Other Expense, Net | -395 | -204 | -690 | -653 | |
Income before Income Taxes | 3,886 | 5,530 | 6,751 | 9,423 | |
Income Taxes | -1,089 | -1,249 | -1,834 | -2,255 | |
Net Income | 2,797 | 4,281 | 4,917 | 7,168 | |
Business to Business Products | |||||
Segment Reporting Information | |||||
Assets | 55,716 | 55,716 | 53,823 | ||
Segment Net Sales | 23,047 | 25,264 | 46,695 | 49,179 | |
Segment Income | 7,443 | 7,993 | 14,314 | 15,644 | |
Retail and Wholesale Products | |||||
Segment Reporting Information | |||||
Assets | 95,768 | 95,768 | 95,712 | ||
Segment Net Sales | 41,596 | 44,041 | 83,992 | 83,672 | |
Segment Income | 1,262 | 2,982 | 2,148 | 4,257 | |
Unallocated Assets | |||||
Segment Reporting Information | |||||
Assets | $32,830 | $32,830 | $36,669 |
Operating_Segment_Narrative_De
Operating Segment Narrative (Details) | 6 Months Ended |
Jan. 31, 2015 | |
segment | |
Segment Reporting Information | |
Number of Reportable Segments | 2 |
StockBased_Compensation_Stock_
Stock-Based Compensation Stock Option (Details) (Stock Options, USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jul. 31, 2014 |
Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Options outstanding, beginning balance | 44 | |||
Options exercisable, beginning balance | 44 | |||
Exercised, number of shares | 0 | 0 | -1 | |
Options outstanding, ending balance | 43 | 43 | 44 | |
Options exercisable, ending balance | 43 | 43 | 44 | |
Options outstanding, weighted average exercise price, beginning balance | $15.43 | |||
Options exercisable, weighted average exercise price, beginning balance | $15.43 | |||
Exercised, weighted average exercise price | $15.37 | |||
Options outstanding, weighted average exercise price, ending balance | $15.43 | $15.43 | $15.43 | |
Options exercisable, weighted average exercise price, ending balance | $15.43 | $15.43 | $15.43 | |
Options outstanding, weighted average remaining contractual term | 1 year 4 months 29 days | 1 year 10 months 25 days | ||
Options exercisable, weighted average remaining contractual term | 1 year 4 months 29 days | 1 year 10 months 25 days | ||
Options outstanding, aggregate intrinsic value, beginning balance | $611 | |||
Options exercisable, aggregate intrinsic value, beginning balance | 611 | |||
Exercised, aggregate intrinsic value | 13 | |||
Options outstanding, aggregate intrinsic value, ending balance | 661 | 661 | 611 | |
Options exercisable, aggregate intrinsic value, ending balance | $661 | $661 | $611 |
StockBased_Compensation_Summar
Stock-Based Compensation Summary of Restricted Stock Transactions (Details) (Restricted Stock, USD $) | 3 Months Ended | 6 Months Ended |
Jan. 31, 2014 | Jan. 31, 2015 | |
Restricted Stock | ||
Share-based Compensation Arrangement by Share-based Payment Award | ||
Non-vested restricted stock outstanding, beginning balance | 122,000 | |
Granted, number of shares | 0 | 11,000 |
Vested, number of shares | -25,000 | |
Forfeitures, number of shares | -2,000 | |
Non-vested restricted stock outstanding, ending balance | 106,000 | |
Non-vested restricted stock outstanding, weighted average grant date fair value, beginning balance | $27.31 | |
Granted, weighted average grant date fair value | $28.68 | |
Vested, weighted average grant date fair value | $21.82 | |
Forfeiture, weighted average grant date fair value | $31.15 | |
Non-vested restricted stock outstanding, weighted average grant date fair value, ending balance | $28.69 |
StockBased_Compensation_Narrat
Stock-Based Compensation Narrative (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 | |
Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Exercised, number of shares | 0 | 0 | -1,000 | |
Cash Received from Exercise of Stock Options | $15,000 | $51,000 | ||
Tax Benefit Realized from Exercise of Stock Options | 3,000 | 24,000 | ||
Options, Granted (shares) | 0 | 0 | ||
Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Restricted Stock Granted, Number (shares) | 0 | 11,000 | ||
2006 Plan | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Number Authorized (shares) | 937,500 | 937,500 | ||
2006 Plan | Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Award Vesting Period, Minimum (years) | 2 years | |||
Award Vesting Period, Maximum (years) | 5 years | |||
Share-based Compensation Expense | 348,000 | 319,000 | $656,000 | $560,000 |
2006 Plan - Director Stock Option | Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Award Vesting Period (Years) | 1 year | |||
2006 Plan - Employee Stock Options | Stock Options | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Annual Vesting Percentage | 25.00% | |||
Number of years after grant date vesting starts (years) | 2 years | |||
Number of consecutive years vesting occurs after initial vest date (years) | 3 years | |||
Common Stock | Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award | ||||
Restricted Stock Granted, Number (shares) | 2,000 |
Accumulated_Other_Comprehensiv2
Accumulated Other Comprehensive Income (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Thousands, unless otherwise specified | Jan. 31, 2015 | Jan. 31, 2014 | Jan. 31, 2015 | Jan. 31, 2014 |
Accumulated Other Comprehensive Income | ||||
Accumulated Other Comprehensive Income, Balance, beginning | ($8,263) | |||
Other comprehensive loss, before reclassifications, net of tax | -446 | |||
Amounts reclassified from accumulated other comprehensive income, net of tax | 87 | |||
Net current-period other comprehensive income (loss), net of tax | -259 | -165 | -359 | -183 |
Accumulated Other Comprehensive Income, Balance, ending | -8,622 | -8,622 | ||
Unrealized Gain (Loss) on Marketable Securities | ||||
Accumulated Other Comprehensive Income | ||||
Accumulated Other Comprehensive Income, Balance, beginning | 114 | |||
Other comprehensive loss, before reclassifications, net of tax | -9 | |||
Amounts reclassified from accumulated other comprehensive income, net of tax | -105 | |||
Net current-period other comprehensive income (loss), net of tax | -114 | |||
Accumulated Other Comprehensive Income, Balance, ending | 0 | 0 | ||
Pension and Postretirement Health Benefits | ||||
Accumulated Other Comprehensive Income | ||||
Accumulated Other Comprehensive Income, Balance, beginning | -8,632 | |||
Other comprehensive loss, before reclassifications, net of tax | 0 | |||
Amounts reclassified from accumulated other comprehensive income, net of tax | 192 | |||
Net current-period other comprehensive income (loss), net of tax | 192 | |||
Accumulated Other Comprehensive Income, Balance, ending | -8,440 | -8,440 | ||
Cumulative Translation Adjustment | ||||
Accumulated Other Comprehensive Income | ||||
Accumulated Other Comprehensive Income, Balance, beginning | 255 | |||
Other comprehensive loss, before reclassifications, net of tax | -437 | |||
Amounts reclassified from accumulated other comprehensive income, net of tax | 0 | |||
Net current-period other comprehensive income (loss), net of tax | -437 | |||
Accumulated Other Comprehensive Income, Balance, ending | ($182) | ($182) |
Accumulated_Other_Comprehensiv3
Accumulated Other Comprehensive Income Narrative (Details) (USD $) | 6 Months Ended |
Jan. 31, 2015 | |
Accumulated Other Comprehensive Income | |
Tax for reclassification adjustment from AOCI for pension and other postretirement benefits | $117,000 |